(Q44030080)

29 November 2017

title

CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships (English)

1 reference

29 November 2017

0 references

Dean A Wacker

1

1 reference

29 November 2017

Joseph B Santella

2

1 reference

29 November 2017

Daniel S Gardner

3

1 reference

29 November 2017

Jeffrey G Varnes

4

1 reference

29 November 2017

Melissa Estrella

5

1 reference

29 November 2017

George V DeLucca

6

1 reference

29 November 2017

Soo S Ko

7

1 reference

29 November 2017

Keiichi Tanabe

8

1 reference

29 November 2017

Paul S Watson

9

1 reference

29 November 2017

Patricia K Welch

10

1 reference

29 November 2017

Maryanne Covington

11

1 reference

29 November 2017

Nicole C Stowell

12

1 reference

29 November 2017

Eric A Wadman

13

1 reference

29 November 2017

Paul Davies

14

1 reference

29 November 2017

Kimberly A Solomon

15

1 reference

29 November 2017

Robert C Newton

16

1 reference

29 November 2017

George L Trainor

17

1 reference

29 November 2017

Steven M Friedman

18

1 reference

29 November 2017

Carl P Decicco

19

1 reference

29 November 2017

John V Duncia

20

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

29 November 2017

published in

1 reference

29 November 2017

volume

12

1 reference

29 November 2017

issue

13

1 reference

29 November 2017

page(s)

1785-1789

1 reference

Eosinophilic Inflammation in Asthma

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Cloning and functional expression of a human eosinophil CC chemokine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Cloning, expression, and characterization of the human eosinophil eotaxin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Discovery of a novel CCR3 selective antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Synthesis and resolution of the novel appetite suppressant 2-benzylmorpholine, a nonstimulant isomer of phenmetrazine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Preparation and use of tetra-n-butylammonium per-ruthenate (TBAP reagent) and tetra-n-propylammonium per-ruthenate (TPAP reagent) as new catalytic oxidants for alcohols

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

Unsymmetrical heterobiaryl synthesis. A highly efficient palladium-catalyzed cross-coupling reaction of heteroaryl trialkylstannanes with aryl halides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900206-8

7 January 2021

10.1016/S0960-894X(02)00206-8

Identifiers

DOI

1 reference

29 November 2017

1 reference